Title:
【発明の名称】中枢神経系障害の治療におけるグラチラマーアセテート(共重合体1)の使用
Document Type and Number:
Japanese Patent JP2003535118
Kind Code:
A
Abstract:
The present invention involves the administration of Copolymer 1 (glatiramer acetate) to treat inflammatory, non-autoimmune central nervous system (CNS) diseases, alleviate the symptoms thereof, inhibit the activity of matrix metalloproteinases and suppress cytokine production by T lymphocytes.
Inventors:
Yeon, Bui Wee
Chabot, Sophie
Chabot, Sophie
Application Number:
JP2002501401A
Publication Date:
November 25, 2003
Filing Date:
June 05, 2001
Export Citation:
Assignee:
Teva Pharmaceutical Industries Limited
International Classes:
A61K9/72; A61K31/785; A61K38/55; A61K45/00; A61P25/00; A61P25/16; A61P25/28; A61P27/06; A61P29/00; A61P31/04; A61P31/18; A61P35/00; A61P43/00; A61K9/02; (IPC1-7): A61K38/55; A61K9/02; A61K9/72; A61K45/00; A61P25/00; A61P25/16; A61P25/28; A61P27/06; A61P29/00; A61P31/04; A61P31/18; A61P35/00; A61P43/00
Attorney, Agent or Firm:
Takehiko Suzue (3 outside)